Track topics on Twitter Track topics that are important to you
BOSTON, MA--(Marketwired - June 03, 2015) - BBK Worldwide, a leading clinical trial marketing firm, will lead five sessions at the DIA 2015 52nd Annual Meeting, to be held at the Walter E. Washington Convention Center in Washington, DC, June 14-18. The company will also unveil its latest software offerings and demo its suite of clinical research mobile apps for study patients and research sites at booth #2026. Session details are as follows:
"Are You Patient Centric? Why Your Answer Must Be Yes" (Innovation Theater)Date/Time:
Monday, June 15, 4:15-4:45 p.m. EDT Panelists:
Bonnie A. Brescia, Founding Principal, BBK Worldwide; Christel Marchand Aprigliano, CEO, the Diabetes Collective; and Claire Meunier, Vice President, Research Engagement, Michael J. Fox Foundation
"Developing Online Communities: Perspectives for Site and Patient Engagement" (Symposium)Date/Time:
Tuesday, June 16, 1:30-2:30 p.m. EDT Speakers:
Ms. Brescia (Chair); Nancy Mulligan, Senior Director, Operations, Patient and Physician Services, UBC: An Express Scripts Company; and Vladimir Pyagay, Clinical Solutions Manager, Transperfect
"mHealth: A New Era in Patient Engagement" (Innovation Theater)Date/Time:
Tuesday, June 16, 3:00-3:30 p.m. EDTPanelists:
Matthew Stumm, Principal, Creative and Media Strategy, BBK Worldwide; Larry Suarez, Mobile Architect, Oracle, mHealth Researcher, Landon Pediatrics Foundation; and Dr. Chris Landon, CEO, Landon Pediatrics Foundation, CMO, CareThings
"Bringing Clinical Trial Practices into the 21st
Tuesday, June 16, 3:30-5:00 p.m. EDT Speakers:
Jaime Cohen, Strategic Consultation and Research, BBK Worldwide; Judith Teall, RN, Director of Clinical Excellence, Exco InTouch; Cecilia Tran-Muchowski, Senior Clinical Program Manager, Gilead Sciences, Inc.; and Jennifer M. Allen, Senior Manager, Client Engagement, UBC: An Express Scripts Company
"Rare Diseases: Patients, Health Care Providers, Caregivers and Advocates as Equal Partners in Clinical Trial Process" (Forum)Date/Time:
Wednesday, June 17, 3:30-4:30 p.m. EDT Presenters:
Ms. Cohen; Barbara Szymaszek, Advocacy, Diversity and Patient Engagement, Bristol-Myers Squibb Company (Chair); and Patricia Furlong, BSN Founding President and CEO, Parent Project Muscular Dystrophy
For additional session details please visit the BBK blog here. Visit BBK booth #2026 to learn more about the company's software solutions and consulting services for improved patient recruitment and engagement. Members of the media and analyst communities interested in meeting with BBK Worldwide at the show can contact Juli Greenwood at 617-515-8412 or firstname.lastname@example.org for scheduling.
Follow @BBKWorldwide on Twitter and join the conversation with #DIA2015 and #BBKatDIA.
About the DIA Annual Meeting
The DIA Annual Meeting is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products, all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. For more information, visit: www.diahome.org.
About BBK Worldwide
With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment and engagement for the clinical trial industry. BBK's innovative software solutions and consulting services leverage the company's adaptive recruitment methodology to protect global enrollment integrity, specifically within an ever-changing or threatened landscape. For more information, visit www.bbkworldwide.com.
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...